Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 13, 1997

View Archived Issues

French researcher discloses preventive effects of tryptamine derivatives

New approach to obesity gene research at Lilly

New topoisomerase I inhibitors synthesized at Rutgers

Dual TNF/PDE IV inhibitors described by Chiroscience

Allergan claims retinoid-like compounds

NO donors claimed by Searle for cardiovascular applications

MRC scientists investigate role of somatostatin receptors in the CNS

French investigators announce success of gene therapy for CF

Millennium/Roche obesity collaboration results in another significant discovery

AutoImmune initiates clinical trials in transplant rejection

Gene therapy for AIDS to enter clinical testing in U.S.

Betafectin clinical update

Chemopreventive properties of resveratrol publicized

Connective Therapeutics commences phase I/II of TCR vaccine for multiple sclerosis

Bio-Technology General's OxSODrol tested for safety and efficacy

Schering-Plough selects Corvas thrombin inhibitor for development

OXIS files IND for BXT-51072

Biopool enters option agreement for assay technology

Cell Genesys signs cancer gene therapy R&D collaborations

NeXstar reveals new oligonucleotide synthesis method

Palatin, Nihon Medi-Physics forge licensing agreement for diagnostics

Biometric Imaging and Immucor sign marketing agreement

Ventus progressing well in phase III

TLC ELL-12 in toxicology testing

Viracept expanded access program broadened

Update on Cypros' CPC-211 and CPC-111

Positive phase III results reported for SCF

The Liposome Company's Abelcet receives marketing approval in 14th country

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Hippocratic loath? ‘Harm’ threat from ACIP’s proposed HBV shift
BioWorld
Individual liberty and choice vs. wider public health became one predictable hinge upon which swung the often-acerbic debates at the CDC’s Advisory Committee for...
Høeg appointment as acting CDER director tied to vaccine strategy?
BioWorld
After a more than 13-year period of stability with Janet Woodcock as the head of CDER, with Patrizia Cavazzoni taking charge during the next four years of former...
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...